MCKHANN CHAS (President and CEO) received a stock award from APOLLO ENDOSURGERY, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/16/2022ACC: 0001251769-22-000053
DirectorOfficer· President and CEO
Since Mar 2021
+571.78K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
571.78K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+112.61K
Price / share
—
Trade value
—
% of position
19.5%
6/14/2022
577.27K→689.88K
Total
Net shares
+112.61K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/14/2022 | A · Award | +112.61K | — | — | 19.5% | 577.27K | 689.88K |
| Total | +112.61K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
459.17K shares
Shares
+459.17K
Strike price
3.95
Held after
459.17K
Exercisable
—
6/14/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock459.17K shares | 6/14/2022 | A · Award | +459.17K | 3.95 | — | 459.17K |